RATIONAL THERAPY IN RA Issues in implementing a treat-to-target approach in RA

被引：3

作者：

Cohen, Marc D. ^{[1
]}

Keystone, Edward C. ^{[2
]}

机构：

[1] Univ Colorado, Med Ctr, Div Rheumatol, Denver, CO 80218 USA

[2] Mt Sinai Hosp, Rebecca MacDonald Ctr Arthrit & Autoimmune Dis, Toronto, ON M5T 3L9, Canada

来源：

NATURE REVIEWS RHEUMATOLOGY | 2013年 / 9卷 / 03期

关键词：

EARLY RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY SCORE; COHORT;

D O I：

10.1038/nrrheum.2013.18

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The treat-to-target approach has been a major breakthrough in the treatment of rheumatoid arthritis. Although this strategy has been evaluated in many clinical studies, whether a high level of adherence is feasible in real-world clinical practice remains uncertain. Cohen, M. D. & Keystone, E. C. Nat. Rev. Rheumatol. 9, 137-138(2013); published online 12 February 2013; doi:10.1038/nrrheum.2013.18

引用

页码：137 / 138

页数：2

共 7 条

[1]

Akhavan P., 2010, ARTHRITIS RHEUM S, V62, pS144

[2]

Akhavan P, 2012, ARTHRITIS RHEUM-US, V64, pS892

[3]

Akhavan PS, 2011, ARTHRITIS RHEUM-US, V63, pS127

[4] State-of-the-art: rheumatoid arthritis [J].

McInnes, Iain B. ;

O'Dell, James R. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (11) :1898-1906

[5] Increasing Treatment in Early Rheumatoid Arthritis Is Not Determined by the Disease Activity Score But by Physician Global Assessment: Results from the CATCH Study [J].

Pyne, Lonnie ;

Bykerk, Vivian P. ;

Boire, Gilles ;

Haraoui, Boulos ;

Hitchon, Carol ;

Thorne, J. Carter ;

Keystone, Edward C. ;

Pope, Janet E. .

JOURNAL OF RHEUMATOLOGY, 2012, 39 (11) :2081-2087

[6] Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort [J].

Vermeer, Marloes ;

Kuper, Hillechiena H. ;

Moens, Hein J. Bernelot ;

Hoekstra, Monique ;

Posthumus, Marcel D. ;

van Riel, Piet L. C. M. ;

van de Laar, Mart A. F. J. .

ARTHRITIS RESEARCH & THERAPY, 2012, 14 (06)

[7] The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic - Discordance between assessment measures and limitations in questionnaire use for regulatory purposes [J].

Wolfe, F ;

Michaud, K ;

Pincus, T ;

Furst, D ;

Keystone, E .

ARTHRITIS AND RHEUMATISM, 2005, 52 (12) :3873-3879

← 1 →